BioAdaptives, Inc.
BDPT
$0.00
$0.000.00%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 696.88% | 3,285.71% | 43.31% | -60.80% | -90.99% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 696.88% | 3,285.71% | 43.31% | -60.80% | -90.99% |
| Cost of Revenue | -90.84% | -91.18% | -93.56% | -96.83% | 36.70% |
| Gross Profit | 133.62% | 120.64% | 116.30% | 106.70% | -494.95% |
| SG&A Expenses | -0.51% | 42.70% | 108.12% | 366.93% | 286.34% |
| Depreciation & Amortization | 500.00% | -- | 110.53% | 128.09% | -96.52% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -5.65% | 29.45% | 77.69% | 246.86% | 215.11% |
| Operating Income | 7.93% | -26.54% | -78.44% | -266.71% | -254.20% |
| Income Before Tax | -52.25% | -86.42% | -73.26% | -39.05% | 0.87% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -52.25% | -86.42% | -73.26% | -39.05% | 0.87% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -52.25% | -86.42% | -73.26% | -39.05% | 0.87% |
| EBIT | 7.93% | -26.54% | -78.44% | -266.71% | -254.20% |
| EBITDA | 8.45% | -25.97% | -78.35% | -276.93% | -324.89% |
| EPS Basic | -29.44% | -4.95% | -0.49% | 9.31% | 34.39% |
| Normalized Basic EPS | -46.52% | -20.97% | -14.12% | 4.71% | 14.16% |
| EPS Diluted | -36.23% | -7.67% | -2.86% | 6.58% | 31.62% |
| Normalized Diluted EPS | -57.65% | -20.97% | -14.12% | 4.71% | 14.16% |
| Average Basic Shares Outstanding | 32.06% | 45.28% | 41.81% | 16.92% | 23.24% |
| Average Diluted Shares Outstanding | 759.51% | 45.28% | 41.81% | 16.92% | 23.24% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |